4 Growth Biotech investors in San Francisco
As of October 4, 2026, DryPowder lists 4 growth Biotech venture funds in San Francisco. Their median published check range is $500K–$25M (3 of 4 funds publish one). None has filed a verified SEC Form D in the last 90 days.
Free fund match
Which Growth Biotech funds in San Francisco are writing checks right now?
About 30 seconds. No signup or card needed. Ranked by thesis fit and check size.
- funds listed
- 4
- median check (3 of 4 publish one)
- $500K–$25M
- filed an SEC Form D in the last 90 days
- 0
- last updated, 2026
- Oct 4
All 4 Growth Biotech funds in San Francisco
- $500K–$25MGrowth
Kleiner Perkins partners with visionary founders to build transformative companies that change how the world works. The fund emphasizes team…
5 partners listed - $500K–$50MSeedGrowth
Bold, early, impactful ventures with brutal honesty. Believe in world-class teams making contrarian bets on impossibly big ideas, from AI to…
1 partner listed - SeedGrowth
Back audacious founders through dedicated early and growth practices with founder-focused, long-term support across multiple sectors where AI is…
Partners not yet listed - $1M–$25MSeedGrowth
Deep tech venture capital backing brilliant entrepreneurs addressing the hardest, highest-stakes problems in the world, using AI to unlock potential…
Partners not yet listed
How this list is built
DryPowder lists every fund with a public profile tagged Growth and Biotech and headquartered in San Francisco. Funds whose largest published check is $5M or less come first; inside each group, funds with a verified SEC Form D in the last 30 days lead, then profile quality decides. Form D dates come from SEC EDGAR, and SPV and single-deal filings are dropped. Check sizes are what each fund publishes; the median uses only the 3 funds that publish one.
Related investor lists
Biotech at other stages
Growth investors by sector
Hubs
How DryPowder compares
Frequently asked questions
How many Growth Biotech VCs in San Francisco are there?
As of October 4, 2026, DryPowder lists 4 growth Biotech venture funds in San Francisco with a public profile. The first 4 on this page are Kleiner Perkins, Khosla Ventures (Seed), Bessemer Venture Partners (Seed) and Data Collective (DCVC).
Which Growth Biotech VCs in San Francisco are actively investing right now?
None of the 4 filed a verified SEC Form D in the last 90 days. A Form D is filed when a fund starts raising; SPVs and single-deal vehicles are not counted.
What check size do Growth Biotech VCs in San Francisco write?
The median published range is $500K–$25M, across the 3 of 4 funds that publish a check size. Published checks on this list run from $500K to $50M.
How does DryPowder build this list?
A fund is listed when its public profile is tagged Growth and Biotech and its headquarters is San Francisco. Funds whose largest published check is $5M or less come first; within each group, funds that filed a Form D in the last 30 days lead, then profile quality decides. Form D dates come from SEC EDGAR, with SPVs excluded. Data as of October 4, 2026.
Sources
- Website: Kleiner Perkins website
- Website: Khosla Ventures (Seed) website
- Website: Bessemer Venture Partners (Seed) website
- Website: Data Collective (DCVC) website
- Method: How DryPowder builds its data
Updated